268 related articles for article (PubMed ID: 16354237)
21. [Characterization of the NPH2 gene, coding for the glomerular protein podocin, implicated in a familial form of cortico-resistant nephrotic syndrome transmitted as an autosomal recessive].
Boute N; Roselli S; Gribouval O; Niaudet P; Gubler MC; Antignac C
Nephrologie; 2002; 23(1):35-6. PubMed ID: 11908478
[No Abstract] [Full Text] [Related]
22. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele.
Tsukaguchi H; Sudhakar A; Le TC; Nguyen T; Yao J; Schwimmer JA; Schachter AD; Poch E; Abreu PF; Appel GB; Pereira AB; Kalluri R; Pollak MR
J Clin Invest; 2002 Dec; 110(11):1659-66. PubMed ID: 12464671
[TBL] [Abstract][Full Text] [Related]
23. NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms.
Caridi G; Perfumo F; Ghiggeri GM
Pediatr Res; 2005 May; 57(5 Pt 2):54R-61R. PubMed ID: 15817495
[TBL] [Abstract][Full Text] [Related]
24. Infantile steroid-resistant nephrotic syndrome associated with double homozygous mutations of podocin.
Caridi G; Berdeli A; Dagnino M; Di Duca M; Mir S; Cura A; Ravazzolo R; Ghiggeri GM
Am J Kidney Dis; 2004 Apr; 43(4):727-32. PubMed ID: 15042551
[TBL] [Abstract][Full Text] [Related]
25. WT-1 and NPHS2 mutation analysis in patients with non-familial steroid-resistant focal-segmental glomerulosclerosis.
Löwik MM; Levtchenko EN; Monnens LA; van den Heuvel LP
Clin Nephrol; 2003 Feb; 59(2):143-6. PubMed ID: 12608558
[TBL] [Abstract][Full Text] [Related]
26. NPHS2 mutations in children with steroid-resistant nephrotic syndrome.
Otukesh H; Ghazanfari B; Fereshtehnejad SM; Bakhshayesh M; Hashemi M; Hoseini R; Chalian M; Salami A; Mehdipor L; Rahiminia A
Iran J Kidney Dis; 2009 Apr; 3(2):99-102. PubMed ID: 19395786
[TBL] [Abstract][Full Text] [Related]
27. Nucleotide variations in the NPHS2 gene in Greek children with steroid-resistant nephrotic syndrome.
Megremis S; Mitsioni A; Mitsioni AG; Fylaktou I; Kitsiou-Tzelli S; Stefanidis CJ; Kanavakis E; Traeger-Synodinos J
Genet Test Mol Biomarkers; 2009 Apr; 13(2):249-56. PubMed ID: 19371226
[TBL] [Abstract][Full Text] [Related]
28. Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant.
Machuca E; Hummel A; Nevo F; Dantal J; Martinez F; Al-Sabban E; Baudouin V; Abel L; Grünfeld JP; Antignac C
Kidney Int; 2009 Apr; 75(7):727-35. PubMed ID: 19145239
[TBL] [Abstract][Full Text] [Related]
29. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
[TBL] [Abstract][Full Text] [Related]
30. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
[TBL] [Abstract][Full Text] [Related]
31. The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis.
Lu L; Wan H; Yin Y; Feng WJ; Wang M; Zou YC; Huang B; Wang DT; Shi Y; Zhao Y; Wei LB
Int Urol Nephrol; 2014 Jul; 46(7):1383-93. PubMed ID: 24715228
[TBL] [Abstract][Full Text] [Related]
32. Another autosomal recessive form of focal glomerulosclerosis with neurological findings.
Nakazato H; Hattori S; Karashima S; Kawano T; Seguchi S; Kanahori M; Endo F
Pediatr Nephrol; 2002 Jan; 17(1):16-9. PubMed ID: 11793129
[TBL] [Abstract][Full Text] [Related]
33. NPHS2 variation in focal and segmental glomerulosclerosis.
Tonna SJ; Needham A; Polu K; Uscinski A; Appel GB; Falk RJ; Katz A; Al-Waheeb S; Kaplan BS; Jerums G; Savige J; Harmon J; Zhang K; Curhan GC; Pollak MR
BMC Nephrol; 2008 Sep; 9():13. PubMed ID: 18823551
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathology of nephrotic syndrome in childhood: a contemporary approach to diagnosis.
Liapis H
Pediatr Dev Pathol; 2008; 11(4):154-63. PubMed ID: 18462046
[TBL] [Abstract][Full Text] [Related]
35. Nephrotic Syndrome With Mutations in NPHS2: The Role of R229Q and Implications for Genetic Counseling.
Rood IM; Deegens JKJ; Lugtenberg D; Bongers EMHF; Wetzels JFM
Am J Kidney Dis; 2019 Mar; 73(3):400-403. PubMed ID: 30241959
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis.
Caridi G; Bertelli R; Carrea A; Di Duca M; Catarsi P; Artero M; Carraro M; Zennaro C; Candiano G; Musante L; Seri M; Ginevri F; Perfumo F; Ghiggeri GM
J Am Soc Nephrol; 2001 Dec; 12(12):2742-2746. PubMed ID: 11729243
[TBL] [Abstract][Full Text] [Related]
37. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).
Hinkes BG; Mucha B; Vlangos CN; Gbadegesin R; Liu J; Hasselbacher K; Hangan D; Ozaltin F; Zenker M; Hildebrandt F;
Pediatrics; 2007 Apr; 119(4):e907-19. PubMed ID: 17371932
[TBL] [Abstract][Full Text] [Related]
38. The mutation-dependent pathogenicity of NPHS2 p.R229Q: A guide for clinical assessment.
Mikó Á; K Menyhárd D; Kaposi A; Antignac C; Tory K
Hum Mutat; 2018 Dec; 39(12):1854-1860. PubMed ID: 30260545
[TBL] [Abstract][Full Text] [Related]
39. The heart of children with steroid-resistant nephrotic syndrome: is it all podocin?
Frishberg Y; Feinstein S; Rinat C; Becker-Cohen R; Lerer I; Raas-Rothschild A; Ferber B; Nir A
J Am Soc Nephrol; 2006 Jan; 17(1):227-31. PubMed ID: 16291839
[TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of the PLCE1 gene in steroid resistant nephrotic syndrome.
Boyer O; Benoit G; Gribouval O; Nevo F; Pawtowski A; Bilge I; Bircan Z; Deschênes G; Guay-Woodford LM; Hall M; Macher MA; Soulami K; Stefanidis CJ; Weiss R; Loirat C; Gubler MC; Antignac C
J Med Genet; 2010 Jul; 47(7):445-52. PubMed ID: 20591883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
